IL6 and breast carcinoma: Furthermore, MSCs promote various malignant features; they control the metastatic ability of breast cancer cells by inducing EMT through the secretion of PDGF-D [196], TGF-β1 [197], IL-6, and VEGF [198] and promote cancer cell migration through the release of a plethora of chemokines such as CCL5 [199], CXCL1 and CXCL5 [200], CXCL9, CXCL10, and CXCL11 [201] or SDF-1 [202].